Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Saved in:
| Title: | Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. |
|---|---|
| Authors: | Stuver R; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Horwitz SM; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Advani RH; Stanford University, Stanford, California, USA., Vose JM; University of Nebraska Medical Center, Omaha, Nebraska, USA., Lee HJ; MD Anderson Cancer Center, Houston, Texas, USA., Mehta-Shah N; Washington University in St. Louis, St. Louis, Missouri, USA., Zain JM; City of Hope, Duarte, California, USA., Haverkos B; University of Colorado, Boulder, Colorado, USA., Lechowicz MJ; Emory University, Atlanta, Georgia, USA., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Pham LQ; Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA., Leyden E; University of Nebraska Medical Center, Omaha, Nebraska, USA., Ansell SM; Mayo Clinic, Rochester, Minnesota, USA., Lunning MA; University of Nebraska Medical Center, Omaha, Nebraska, USA. |
| Source: | British journal of haematology [Br J Haematol] 2023 Aug; Vol. 202 (3), pp. 525-529. Date of Electronic Publication: 2023 May 22. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.18885 |
